178 related articles for article (PubMed ID: 27574181)
1. Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation.
He QL; Minn I; Wang Q; Xu P; Head SA; Datan E; Yu B; Pomper MG; Liu JO
Angew Chem Int Ed Engl; 2016 Sep; 55(39):12035-9. PubMed ID: 27574181
[TBL] [Abstract][Full Text] [Related]
2. Triptolide and Its Derivatives as Cancer Therapies.
Noel P; Von Hoff DD; Saluja AK; Velagapudi M; Borazanci E; Han H
Trends Pharmacol Sci; 2019 May; 40(5):327-341. PubMed ID: 30975442
[TBL] [Abstract][Full Text] [Related]
3. Triptolide-targeted delivery methods.
Xu H; Liu B
Eur J Med Chem; 2019 Feb; 164():342-351. PubMed ID: 30605832
[TBL] [Abstract][Full Text] [Related]
4. Triptolide: A new star for treating human malignancies.
Yan P; Sun X
J Cancer Res Ther; 2018 Jun; 14(Supplement):S271-S275. PubMed ID: 29970675
[TBL] [Abstract][Full Text] [Related]
5. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment.
Wu B; Lu ST; Zhang LJ; Zhuo RX; Xu HB; Huang SW
Int J Nanomedicine; 2017; 12():1853-1862. PubMed ID: 28331310
[TBL] [Abstract][Full Text] [Related]
6. Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin.
Yuan ZX; Wu XJ; Mo J; Wang YL; Xu CQ; Lim LY
Eur J Pharm Biopharm; 2015 Aug; 94():363-71. PubMed ID: 26117184
[TBL] [Abstract][Full Text] [Related]
7. LLDT-288, a novel triptolide analogue exhibits potent antitumor activity in vitro and in vivo.
Xu H; Fan X; Zhang G; Liu X; Li Z; Li Y; Jiang B
Biomed Pharmacother; 2017 Sep; 93():1004-1009. PubMed ID: 28724258
[TBL] [Abstract][Full Text] [Related]
8. XPB, a subunit of TFIIH, is a target of the natural product triptolide.
Titov DV; Gilman B; He QL; Bhat S; Low WK; Dang Y; Smeaton M; Demain AL; Miller PS; Kugel JF; Goodrich JA; Liu JO
Nat Chem Biol; 2011 Mar; 7(3):182-8. PubMed ID: 21278739
[TBL] [Abstract][Full Text] [Related]
9. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.
Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC
Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791
[TBL] [Abstract][Full Text] [Related]
10. Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model.
Chen JG; Liu YF; Gao TW
J Liposome Res; 2010 Dec; 20(4):297-303. PubMed ID: 20102297
[TBL] [Abstract][Full Text] [Related]
11. Triptolide-Assisted Phosphorylation of p53 Suppresses Inflammation-Induced NF-κB Survival Pathways in Cancer Cells.
Zheng L; Jia J; Dai H; Wan L; Liu J; Hu L; Zhou M; Qiu M; Chen X; Chang L; Kim JY; Reckamp K; Raz DJ; Xia Z; Shen B
Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533220
[TBL] [Abstract][Full Text] [Related]
12. Molecularly Engineering Triptolide with Aptamers for High Specificity and Cytotoxicity for Triple-Negative Breast Cancer.
He J; Peng T; Peng Y; Ai L; Deng Z; Wang XQ; Tan W
J Am Chem Soc; 2020 Feb; 142(6):2699-2703. PubMed ID: 31910009
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis of novel triptolide-glucose conjugates targeting glucose Transporter-1 and their selective antitumor effect.
Liu Y; Huang J; Wu M; Liu B; Lin Q; Wu J; Ouyang Y; Guo X; Huang R; Zhang Y; Xu J
Eur J Med Chem; 2022 Aug; 238():114463. PubMed ID: 35617856
[TBL] [Abstract][Full Text] [Related]
14. Broad targeting of triptolide to resistance and sensitization for cancer therapy.
Hou ZY; Tong XP; Peng YB; Zhang BK; Yan M
Biomed Pharmacother; 2018 Aug; 104():771-780. PubMed ID: 29807227
[TBL] [Abstract][Full Text] [Related]
15. [Advance in the anti-tumor mechanism of triptolide].
Luo Y; Shi C; Liao M
Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(16):2024-6. PubMed ID: 19938536
[TBL] [Abstract][Full Text] [Related]
16. pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma.
Ling D; Xia H; Park W; Hackett MJ; Song C; Na K; Hui KM; Hyeon T
ACS Nano; 2014 Aug; 8(8):8027-39. PubMed ID: 25093274
[TBL] [Abstract][Full Text] [Related]
17. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo.
Li CJ; Chu CY; Huang LH; Wang MH; Sheu LF; Yeh JI; Hsu HY
Cancer Lett; 2012 Jun; 319(2):203-213. PubMed ID: 22306340
[TBL] [Abstract][Full Text] [Related]
18. Covalent modification of a cysteine residue in the XPB subunit of the general transcription factor TFIIH through single epoxide cleavage of the transcription inhibitor triptolide.
He QL; Titov DV; Li J; Tan M; Ye Z; Zhao Y; Romo D; Liu JO
Angew Chem Int Ed Engl; 2015 Feb; 54(6):1859-63. PubMed ID: 25504624
[TBL] [Abstract][Full Text] [Related]
19. The main anticancer bullets of the Chinese medicinal herb, thunder god vine.
Liu Z; Ma L; Zhou GB
Molecules; 2011 Jun; 16(6):5283-97. PubMed ID: 21701438
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of RNA polymerase III transcription by Triptolide attenuates colorectal tumorigenesis.
Liang X; Xie R; Su J; Ye B; Wei S; Liang Z; Bai R; Chen Z; Li Z; Gao X
J Exp Clin Cancer Res; 2019 May; 38(1):217. PubMed ID: 31122284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
